Mast Therapeutics And Savara Announce Approval To List Common Stock On The Nasdaq Capital Market PR Newswire By John Harbison|2017-04-10T15:56:55-08:00April 10, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Mast Therapeutics And Savara Announce Approval To List Common Stock On The Nasdaq Capital Market Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
